US-guided laser ablation for refractory neoplasms
LA-002
Phase 2 other active
Quick answer
US-guided laser ablation for refractory neoplasms for Refractory Neoplasms is a Phase 2 program (other) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Refractory Neoplasms
- Phase
- Phase 2
- Modality
- other
- Status
- active